These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3288065)

  • 1. Pharmacology of nimodipine. A review.
    Scriabine A; van den Kerckhoff W
    Ann N Y Acad Sci; 1988; 522():698-706. PubMed ID: 3288065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.
    Gomi S; Burnett MG; Karp A; Greenberg JH
    Exp Brain Res; 2004 Apr; 155(4):469-76. PubMed ID: 14752581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological basis for the use of nimodipine in central nervous system disorders.
    Scriabine A; Schuurman T; Traber J
    FASEB J; 1989 May; 3(7):1799-806. PubMed ID: 2565839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.
    Kazda S; Garthoff B; Krause HP; Schlossmann K
    Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of gamma 2-melanocyte-stimulating hormone and nimodipine on cortical blood flow and infarction volume in two rat models of middle cerebral artery occlusion.
    Herz RC; De Wildt DJ; Versteeg DH
    Eur J Pharmacol; 1996 Jun; 306(1-3):113-21. PubMed ID: 8813623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats.
    Uematsu D; Greenberg JH; Hickey WF; Reivich M
    Stroke; 1989 Nov; 20(11):1531-7. PubMed ID: 2815188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular, neuronal, and behavioral effects of long-term Ca2+ channel blockade in aging normotensive and hypertensive rat strains.
    Luiten PG; de Jong GI; Schuurman T
    Ann N Y Acad Sci; 1994 Dec; 747():431-51. PubMed ID: 7847689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-channel blockers: effects on cerebral blood flow and potential uses for acute stroke.
    Gelmers HJ
    Am J Cardiol; 1985 Jan; 55(3):144B-148B. PubMed ID: 2578724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcium antagonists on the cerebral circulation.
    Gelmers HJ
    Am J Cardiol; 1987 Jan; 59(3):173B-176B. PubMed ID: 2433932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimodipine reduces morbidity, mortality after disruption of cerebral blood flow.
    Carmody J; Lilly JK
    W V Med J; 1990 Feb; 86(2):49-51. PubMed ID: 2408232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nimodipine on the production of thromboxane A2 following total global cerebral ischemia.
    Haddon WS; Prough DS; Kong D; Petrozza P
    J Neurosurg; 1988 Sep; 69(3):416-20. PubMed ID: 3404240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular and cerebral effects of nimodipine--an update.
    Brandt L; Andersson KE; Ljunggren B; Säveland H; Ryman T
    Acta Neurochir Suppl (Wien); 1988; 45():11-20. PubMed ID: 3066138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of nimodipine, a calcium antagonist with preferential cerebrovascular activity.
    Kazda S
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():70-3. PubMed ID: 4010868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic value of nimodipine in experimental focal cerebral ischemia. Neurological outcome and histopathological findings.
    Germano IM; Bartkowski HM; Cassel ME; Pitts LH
    J Neurosurg; 1987 Jul; 67(1):81-7. PubMed ID: 3598674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nimodipine on intracellular brain pH, cortical blood flow, and EEG in experimental focal cerebral ischemia.
    Meyer FB; Anderson RE; Yaksh TL; Sundt TM
    J Neurosurg; 1986 Apr; 64(4):617-26. PubMed ID: 3950744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage.
    Uematsu D; Araki N; Greenberg JH; Sladky J; Reivich M
    Neurology; 1991 Jan; 41(1):88-94. PubMed ID: 1985301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats.
    Dreier JP; Windmüller O; Petzold G; Lindauer U; Einhäupl KM; Dirnagl U
    Neurosurgery; 2002 Dec; 51(6):1457-65; discussion 1465-7. PubMed ID: 12445352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of calcium antagonist nimodipine and induced hypertension on cerebral vessel reactivities, cerebral blood flow, cerebral edema and infarction in cats with one hour middle-cerebral-artery occlusion].
    Sakaki T; Ishida T; Sasaoka Y; Thunoda S; Utsumi S
    No Shinkei Geka; 1990 May; 18(5):423-30. PubMed ID: 2385317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
    Gemba T; Ninomiya M; Matsunaga K; Ueda M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):463-7. PubMed ID: 8474028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists decrease capillary wall damage in aging hypertensive rat brain.
    Farkas E; De Jong GI; Apró E; Keuker JI; Luiten PG
    Neurobiol Aging; 2001; 22(2):299-309. PubMed ID: 11182480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.